Oruka Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
855 OAK GROVE AVE., MENLO PARK, CA, 94025
Mailing Address
855 OAK GROVE AVE., MENLO PARK, CA, 94025
Phone
650-606-7910
Fiscal Year End
1231
EIN
363855489
Financial Overview
FY2025
-$83.72M
Net Income
$488.62M
Total Assets
$471.93M
Stockholders' Equity
$61.58M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-3 Shelf registration for future offerings | April 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Rapid advancement of innovative pipeline (ORKA-001, ORKA-002) into mid-stage clinical trials, following a significant corporate merger.
- Focus on ultra-long half-life monoclonal antibodies designed for significantly less frequent dosing (e.g., once or twice-yearly), aiming to enhance patient convenience and adherence.
Insider Trading
STRONG SELL
5 insiders
21 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.